Summit Securities Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Summit Securities Group’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$6.95K	Buy
2023 Q4	–	Sell
2023 Q3	$23K	Buy
2014 Q4	–	Sell
2014 Q3	$36K	Buy
2014 Q2	–	Hold